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Abstract: During the COVID-19 pandemic in Germany, non-pharmaceutical interventions were
imposed to contain the spread of the virus. Based on cross-sectional waves in March, July and
December 2020 of the COVID-19 Snapshot Monitoring (COSMO), the present study investigated the
impact of the introduced measures on the perceived access to health care. Additionally, for the wave
in December, treatment occasion as well as utilization and satisfaction regarding telemedicine were
analysed. For 18–74-year-old participants requiring medical care, descriptive and logistic regression
analyses were performed. During the less strict second lockdown in December, participants reported
more frequently ensured access to health care (91.2%) compared to the first lockdown in March
(86.8%), but less frequently compared to July (94.2%) during a period with only mild restrictions.
In December, main treatment occasions of required medical appointments were check-up visits at
the general practitioner (55.2%) and dentist (36.2%), followed by acute treatments at the general
practitioner (25.6%) and dentist (19.0%), treatments at the physio-, ergo- or speech therapist (13.1%),
psychotherapist (11.9%), and scheduled hospital admissions or surgeries (10.0%). Of the participants,
20.0% indicated utilization of telemedical (15.4% telephone, 7.6% video) consultations. Of them,
43.7% were satisfied with the service. In conclusion, for the majority of participants, access to medical
care was ensured during the COVID-19 pandemic; however, access slightly decreased during phases
of lockdown. Telemedicine complemented the access to medical appointments.
Keywords: COVID-19; SARS-CoV-2; access to health care; health care utilization; telemedicine
1. Introduction
The COVID-19 pandemic affects the health care sector in many ways. On the one hand,
health care providers and health care systems are facing new challenges directly through the
care of patients with COVID-19. Treatment of a new disease needs to be established while
evidence-based recommendations on medical management are limited and constantly
updated [1,2]; at the same time, scarce capacities of staff, intensive care beds and medical
equipment have to be dealt with at the point of rising numbers of COVID-19 patients [1].
On the other hand, extensive non-pharmaceutical interventions (NPI) have been introduced
to contain the spread of severe acute respiratory syndrome corona virus type 2 (SARS-CoV-
2). In many countries, non-COVID-19 treatments have been restricted to ensure capacities
for treatment of severe cases of COVID-19 [3–5]. As a result, also in Germany, elective
surgical interventions have been postponed and cancelled [6–8], services for routine care
such as health check-ups, screenings for cancer or vaccinations have decreased [9–16].
Furthermore, a decline in primary care contacts at general practitioners (GP) or specialists
have been reported [17,18]. Studies have indicated that the utilization of emergency care
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for acute conditions like myocardial infarction or ischemic stroke decreased during the first
months of the COVID-19 pandemic in Germany [8,19–21] and other countries [22–24].
The effects of NPI on medical care have also been investigated from the popula-
tion’s point of view. On the one hand the analyses of previous waves of the COVID-19
Snapshot Monitoring (COSMO) study showed that the majority of participants reported
no difficulties regarding access to medical appointments; however, this proportion was
reduced during the first lockdown compared to July 2020, when measures have been
loosened [9,25]. On the other hand findings suggest that a reduced demand for patients’
care may have additionally led to decreased utilization of health care services [26] as some
people postponed and avoided routine care and even urgent care because of concerns
of COVID-19 [27]. Especially insecurities and people’s fear of exposure to SARS-CoV-2
could play a role in this as well as the intention to not overburden the health care sys-
tem [7,28,29]. In consequence, negative effects of the pandemic on health status are also
feared for persons without COVID-19 disease, particularly for those with chronic medical
conditions [30,31]. Furthermore, the extent to which the provision of telemedical services is
being expanded to deal with the challenges of health care in the pandemic is an important
topic for further research. Even though telemedicine has limited applicability, it could to
some extent mitigate the effects of postponed or cancelled doctor’s appointments and in
many countries a rise in utilization of telemedicine has been reported [32].
In summary, there have been a number of studies on access to health care services in
Germany during the first months of the COVID-19 pandemic; however, findings on the
availability of medical care throughout the further course of the pandemic are yet scarce,
but strongly relevant [33]. In Germany, in mid-March 2020, a set of restrictions to reduce
physical contact was implemented, including the ban of gatherings of more than two
people, a minimum distance of 1.5 metres between people in public, the closing of schools
and day care centres as well as the closure of shops and restaurants [34]. Concurrently,
hospitals were asked to postpone scheduled surgeries and treatments to provide capacity
for treatment of severe cases of COVID-19 [6]. From the end of April, measures were
loosened gradually so that by May restaurants and schools in many German federal
states could be reopened [34]. After a period of mild restrictions during summer, re-
implementation of restrictions started from the 2nd of November in several stages. In
December, contact restrictions were re-enforced; however, schools and shops were not yet
affected (“less strict second lockdown”) [34].
Against this background, one main objective of our study was to examine perceived
access to medical care during three different stages of lockdown over the course of the
COVID-19 pandemic in 2020, i.e., in March after the first implementation of measures
to contain the spread of SARS-CoV-2 (“first lockdown”), in July after the loosening of
restrictions (“period of mild restrictions”) and at the beginning of December in a phase
of reintroduction of regulations though less strict than in spring (“less strict second lock-
down”). Additionally, we present stratified results on the required treatment occasion as
well as the use and satisfaction regarding telemedicine services such as phone or video calls
instead of physical visits for the stage of the second lockdown from a population-based
perspective.
2. Materials and Methods
2.1. Study Sample
The present study is based on data from the serial, cross-sectional COVID-19 Snapshot
Monitoring (COSMO) online survey, initiated in Germany in March 2020. For rapid and
adaptive monitoring of knowledge, risk perceptions, preventive behaviours, and public
trust in the context of the COVID-19 pandemic across countries, the initiating authorities
together with the new Insights Unit at the WHO Regional Office for Europe are providing
a customizable study protocol, a sample questionnaire, a script for data analysis as well as
directions on contextual adaptation and open access procedures [35,36].
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In Germany, the COSMO survey was conducted weekly between 3/4March 2020 and
26/27 May 2020 (waves 1 to 13) and bi-weekly or weekly thereafter (wave 14 to current
wave 43) [37]. For this analysis, data from wave 6 (7/8 April 2020, n = 1022), wave 17
(21/22 July 2020, n = 1001), and wave 28 (1/2 December 2020; n = 1020) were included.
Participants are German-speaking, living in Germany and aged 18 to 74 years. The sample
for each wave is matching the general population in Germany in terms of age, gender,
and residency in a German federal state (Nielsen areas) [35,36]. Participants for whom the
initial question about currently required medical appointments was not applicable were
excluded, resulting in a final sample size of 773 participants for wave 6941 participants for
wave 17, and 868 participants for wave 28.
2.2. Assessment of Variables Related to Access to Health Care Services and Telemedicne
In waves 6, 17, and 28, participants were asked: “Are doctor visits and contacts
necessary for you currently available?” (response options: yes; no; does not apply).
In wave 28, participants were further asked: (1) “What is the reason for doctor visits
or contacts that are currently necessary for you?” (response options, whereby multiple
answers were possible: psychotherapeutic treatment; physiotherapeutic, ergotherapeutic
or speech therapy treatment; check-up visit at general practitioner or specialist; check-
up visit at dentist; acute (urgent) treatment at general practitioner or specialist; acute
(urgent) treatment at dentist; scheduled hospital admission or surgery; other [free text entry
possible]) and (2) “Do you currently use telephone or telemedical contact options instead
of visiting a doctor’s or psychotherapist’s practice?” (response options, whereby multiple
answers were possible: yes, telephone, e.g., telephone consultations; yes, telemedicine,
e.g., video consultations, e-mail contact; no; no need for examination or treatment). If
the latter question was answered with yes regarding the telephone or telemedical contact,
participants were further asked: (3) “Are you satisfied with your telephone or telemedical
consultation?” (response options: completely unsatisfied to completely satisfied on a
seven-point scale).
2.3. Assessment of Sociodemographic Variables and Presence of Chronic Diseases
In accordance to previous studies based on COSMO data, age was categorized into the
following four categories: 18 to 29 years, 30 to 49 years, 50 to 64 years, and 65 to 74 years,
but education was maintained in the assessed three categories: up to 9 years of education,
at least 10 years of education (without general qualification for university entrance), and at
least 10 years of education (with general qualification for university entrance) [9,25]. The
presence of chronic conditions was assessed by asking: “Do you have a chronic disease?”
(response options: yes; no; don’t know).
2.4. Statistical Analysis
Descriptive analyses include the calculation of frequencies and proportions (95%
confidence interval) of sample characteristics and health care services variables. The
logistic regression model considers the perceived access to medical appointments as a
binary dependent variable and the sociodemographic variables as well as the presence of a
chronic condition as independent variables scaled as factors. The criterion for statistical
significance was set at p < 0.05. SAS 9.4 (SAS Institute, Cary, NC, USA) was used for all
statistical analyses.
2.5. Ethics Statement
Informed consent was obtained from all participants included in the study. All
procedures conducted in the COSMO study are in accordance with the ethical standards of
the University of Erfurt institutional research committee [35] and with the 1964 Helsinki
Declaration and its later amendments or comparable ethical standards [25].
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3. Results
3.1. Sample Characteristics
Across the three waves in April, July and December 2020, the participants requiring
access to medical appointments were comparable with regard to sex, age, education and
self-reported presence of a chronic condition (Table 1). The distribution of age and sex
(crossed) in the sample is in accordance with data of the German population provided by
the last German census conducted in 2011 [38] (Supplement Table S1). Regarding education,
more than half of the participants reported to have more or equal to 10 years of education
with a university entrance qualification. Chronic conditions were reported by almost 40%
of the individuals.










% (95%-CI) n % (95%-CI) n % (95%-CI) n
Sex
Male 50.2 (46.7–53.7) 388 48.4 (45.2–51.6) 455 47.7 (44.4–51.0) 414
Female 49.8 (46.3–53.3) 385 51.6 (48.4–54.8) 486 52.3 (49.0–55.6) 454
Age groups
18–29 years 16.4 (14.0–19.2) 127 18.8 (16.4–21.4) 177 17.7 (15.3–20,4) 154
30–49 years 38.2 (34.8–41.6) 295 35.7 (32.7–38.8) 336 37.6 (34.4–40.8) 326
50–64 years 28.3 (25.3–31.6) 219 28.3 (25.5–31.2) 266 28.8 (25.9–31.9) 250
65–74 years 17.1 (14.6–19.9) 132 17.2 (14.9–19.8) 162 15.9 (13.6–18.5) 138
Education
≤9 years of formal education 9.8 (7.9–12.1) 76 13.5 (11.5–15.8) 127 12.1 (10.1–14.4) 105
≥10 years of formal education
without university entrance
qualification
35.7 (32.4–39.2) 276 32.6 (29.7–35.7) 307 33.4 (30.3–36.6) 290
≥10 years of formal education with
university entrance qualification 54.5 (50.9–57.9) 421 53.9 (50.7–57.0) 507 54.5 (51.2–57.8) 473
Chronic condition
Yes 39.7 (36.3–43.2) 307 38.4 (35.3–41.5) 361 37.0 (33.8–40.2) 321
No 55.5 (52.0–59.0) 429 59.6 (56.4–62.7) 561 59.8 (56.5–63.0) 519
Don’t know 4.8 (3.5–6.5) 37 2.0 (1.3–3.1) 19 3.2 (2.2–4.6) 28
95%-CI: 95% confidence interval.
3.2. Perceived Access to Medical Appointments during the COVID-19 Pandemic
In December 2020, the majority of participants indicated to have access to medical
appointments (Table 2). Regarding age groups, the proportion of participants reporting
ensured access to medical appointments increased significantly with older age. While
84.4% of those aged 18–29 reported ensured access, 94.4% and 97.8% in the 50–64 and
65–74 age groups, respectively, agreed with this statement. Confidence intervals did not
overlap between respective groups. Sex, educational background and presence of a chronic
condition had no significant influence on the perceived access to medical appointments.
During the less strict second lockdown from the end of October until the beginning
of December 2020 in Germany, the perceived access to medical appointments was higher
than during the first stricter lockdown in April 2020 and lower than in July 2020 during the
period with only mild restrictions (Table 2). Consistent with wave 28 in December 2020,
both previous waves show the same patterns for the stratified analysis. While there were
no differences observed regarding sex, education and the presence of chronic conditions,
increasing age of the participants was associated with higher reported access to medical
appointments.
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Table 2. Proportion of participants reporting ensured access to medical appointments among participants requiring medical










% (95%-CI) n % (95%-CI) n % (95%-CI) n
Overall 86.8 (84.2–89.0) 671 94.2 (92.5–95.5) 886 91.2 (89.2–93.0) 792
Sex
Male 86.1 (82.3–89.2) 334 93.6 (91.0–95.5) 426 90.6 (87.4–93.0) 375
Female 87.5 (83.8–90.5) 337 94.7 (92.3–96.3) 460 91.9 (89.0–94.0) 417
Age groups
18–29 years 79.5 (71.6–85.7) 101 87.0 (81.2–91.2) 154 84.4 (77.8–89.3) 130
30–49 years 86.8 (82.4–90.2) 256 92.9 (89.6–95.2) 312 89.3 (85.4–92.2) 291
50–64 years 87.7 (82.6–91.4) 192 97.7 (95.1–99.0) 260 94.4 (90.8–96.7) 236
65–74 years 92.4 (86.5–95.9) 122 98.8 (95.2–99.7) 160 97.8 (93.5–99.3) 135
Education
≤9 years of formal education 89.5 (80.3–94.7) 68 94.5 (88.9–97.4) 120 90.5 (83.2–94.8) 95
≥10 years of formal education
without university entrance
qualification
87.0 (82.4–90.4) 240 93.8 (90.5–96.0) 288 90.7 (86.8–93.5) 263
≥10 years of formal education with
university entrance qualification 86.2 (82.6–89.2) 363 94.3 (91.9–96.0) 478 91.8 (88.9–93.9) 434
Chronic condition
Yes 87.6 (83.4–90.9) 269 94.2 (91.2–96.2) 340 91.3 (87.7–93.9) 293
No 86.0 (82.4–89.0) 369 94.1 (91.8–95.8) 528 91.5 (88.8–93.6) 475
Don’t know 89.2 (74.5–95.9) 33 94.7 (70.6–99.3) 18 85.7 (67.5–94.5) 24
95%-CI: 95% confidence interval.
To assess whether the availability of medical services differs between the three phases
of the pandemic independent of effects described above, we performed a logistic regression
model adjusting for multiple covariates sex, age, education and presence of a chronic
condition. The logistic regression model confirmed the observed differences (Supplement
Figure S1 and Table S2). Compared to wave 28 in December 2020, the perceived access
to medical appointments was higher in July 2020 (OR: 1.57, 95%-CI: 1.09–2.26) and lower
in April 2020 (OR: 0.62, 95%-CI: 0.45–0.85). The odds to have ensured access to health
care were not decreased for participants with self-reported chronic conditions compared
to participants without chronic conditions (Figure S1). Regarding sex and education, no
significant differences were observed. However, with increasing age, the odds of reporting
ensured access to medical appointments increased. Defining the age group 18–29 years as
reference, the age groups 30–49 years (OR: 1.87, 95%-CI: 1.34–2.62), 50–64 years (OR: 3.39,
95%-CI: 2.25–5.13) and 65–74 years (OR: 6.65, 95%-CI: 3.66–12.08) showed continuously
increasing odds ratios for ensured access to medical appointments.
3.3. Treatment Occasions
Within wave 28 in December 2020, we additionally assessed the occasion for a required
medical appointment (Table 3). More than half of the participants reported that check-up
visits at their general practitioner (GP) or their specialist were required. More than one third
indicated that a check-up visit at their dentist was required. An acute (urgent) treatment at
GP or specialist was relevant for a quarter of participants and an acute treatment at dentist
was relevant for almost a fifth of participants. Further, treatments at a physiotherapist,
ergotherapist or speech therapist or treatments at a psychotherapist were less frequently
observed. One in ten individuals stated that a scheduled hospital admission or surgery was
required. Other treatment occasions were indicated by 9.0% of respondents and according
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to the sighted free text entries mainly comprised appointments to receive prescriptions,
vaccinations or to participate at screening examinations.
The stratified analysis revealed that check-up visits at the GP or specialist were more
frequently required by participants of older age and with chronic conditions (Table 3).
Interestingly, for acute treatment occasions at the GP or specialist there were no differences
observed between age groups or the presence of a chronic condition.
Regarding check-up visits at the dentist, individuals in younger age groups and with
higher educational background reported more frequently that appointments were necessary
compared to older age groups and participants with lower educational background. In
contrast, for acute treatment occasions at the dentist no differences with respect to age and
educational background were observed.
For psychotherapy, participants with chronic conditions more often indicated that
treatments were required. Similarly, participants with chronic conditions more frequently
reported that physiotherapy, ergotherapy or speech therapy was required. Men and
individuals of younger age groups required treatments in the hospital more often than
women or older age groups, respectively. With respect to all other strata, no differences
were observed for occasions of required medical appointment.
As described above, during the second lockdown in December 2020 for the majority of
participants access to medical appointments was ensured. The stratified analysis confirms
this observation for all treatment occasions (Figure 1). For example, out of all participants
requiring check-up visits at the GP or specialist (55.2%) or dentist (36.3%) (Table 3), the
medical appointment was available for 51.7% or 34.0%, respectively. Contrarily, 3.5% and
2.3% of respondents, respectively, reported they had no access to the required medical ap-
pointment. For all other treatment occasions, fewer participants indicated the requirement
as well as no access to medical appointments.
However, stratified analysis considering the relative proportion of individuals without
access to medical appointment for each required treatment occasion separately revealed
a different picture. More specifically, 16.5% of respondents requiring psychotherapy had
no access to an appointment. For scheduled hospitals admissions or operations, 11.5%
of individuals and for physiotherapy, ergotherapy or speech therapy, 9.6% of individuals
reported their respective appointment was not available. Of participants requiring an acute
appointment at their GP or specialist or at their dentist, this proportion was 8.2% or 8.4%,
respectively; of participants requiring a check-up visit at their GP or specialist or at their
dentist, this proportion was lowest with 6.3% each.
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Figure 1. Proportion of treatment occasions among participants requiring medical appointments stratified by perceived
non-availability (red) and availability (blue) of appointments (wave 28, n = 868). GP: general practitioner.
3.4. Utilization of Telemedcine during the COVID-19 Pandemic
In wave 28 in December 2020, the utilization of telemedicine for the interaction
of physicians with patients via audio and video during the pandemic was additionally
assessed. Overall, 20.0% of the participants requiring a medical appointment indicated that
they had a consultation via telephone, video or both (Supplement Table S3). The remaining
participants either did not utilize telemedical services or had no need. Appointments via
telephone (15.4%) were more frequently reported than video (7.6%). Men utilized both
telephone and telemedicine more frequently than women. While there was no difference
observed regarding the telephone appointments across age groups and educational groups,
video consultations were more frequently utilized by participants of younger age and with
a higher educational background. With regard to chronic condition no differences in the
utilization of telemedical consultations were reported. Respondents who indicated no
access to medical appointments used telemedicine more frequently. Within the group of
participants who had no need for telemedical consultations despite requiring a medical
appointment there were no differences between sex, age and educational groups observed.
When asked about their satisfaction with telemedicine consultations, overall 43.7%
were satisfied (6 or 7 points out of 7 points), 48.9% were neither fully satisfied nor dissat-
isfied (3 to 5 points) and 7.5% were not satisfied (1 to 2 points) (Figure 2). There were no
relevant differences in satisfaction between telephone and video consultations. Women
and men were equally content with the telemedicine appointments. Individuals between
18–29 years were less frequently fully satisfied (23.8%) with the telemedicine appoint-
ments compared to the other age groups. Participants aged 65–74 years and those with
chronic conditions more often reported that they were dissatisfied with the telemedicine
appointments.
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Figure 2. Satisfaction of participants having used telemedicine (wave 28, n = 174) 1 n = 4 participants indicated “don’t
know”. UEQ: university entrance qualification.
4. Discussion
The present study based on data of the population-based COSMO survey shows that
during the course of the COVID-19 pandemic in 2020, access to medical care services
was available for the majority of 18- to 74-year-olds reporting a need for medical care.
However, the proportion of those who reported non-availability of needed medical care
services was corresponding to the strictness of NPI that have been introduced for the
containment of SARS-CoV-2. While check-up visits and acute treatments at the general
practitioner or specialist and at the dentist were the most frequently required treatments,
psychotherapy sessions were the most frequently non-available treatment when considered
in relation to the respective frequency of required treatments. Remarkably, one-fifth of
participants utilized telephone or video consultation instead of visiting a physician’s or
psychotherapist’s practice, and this proportion was higher among those who reported
non-availability of medical care services. Some differences were observed by age, sex,
educational background or the presence of a chronic condition.
4.1. Perceived Access to Medical Appointments during the COVID-19 Pandemic
According to an earlier analysis of the COSMO study, the vast majority stated to
have access to required medical appointments during the first months of the COVID-19
pandemic, although this proportion was lower in April 2020 (86.8%), during the first
lockdown, compared to July 2020 (94.2%), when most NPIs were lifted [9]. This is in
line with another study based on COSMO data from April and July 2020 reporting that
participants mostly denied having difficulties to access medical care [25]. Still, results
from a recent nationwide German Health Update (GEDA 2019/2020) survey covering
data from the beginning of the COVID-19 pandemic until September 2020 indicate a
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temporary decline in both outpatient visits at general practitioners (GP) and specialists
between April and June 2020 compared to the same months in 2019 [18]. The present
study adds that at the beginning of the less strict second lockdown in December 2020, the
perceived access to medical appointments was again reduced (91.2%); however, not to the
same extent as during the first lockdown. NPIs such as mask-wearing, enhanced hygiene,
contact reductions, ban of large public events, recommendations to work from home or for
testing and isolation were in place throughout the pandemic, while closing educational
institutions, restaurants, shopping facilities, border controls, and travel restrictions varied
across time and federal state level [34]. An important indicator of lockdown measures and
their acceptance is overall mobility [39]. Studies showed that in the months when most
NPIs were lifted or gradually loosened (May to October), mobility in Germany increased
to a level comparable to the previous year [40]. With the start of the second lockdown,
mobility fell back below the level of the previous year [41].
Younger participants indicated more often to have no access to medical appointments
throughout all three points in time. Previously, a study on access to health care in Europe
reported younger people having challenges in access to medical appointments [42] and
a population-based survey from the Netherlands and Belgium carried out during the
first lockdown confirmed this observation [43]. Although several studies further report
that scheduled treatments for patients with chronic diseases were frequently cancelled
by health care providers [30,31], in the present study, participants with reported chronic
conditions did not report a lower perceived access to health care. Interestingly, results
from the nationwide GEDA 2019/2020 survey in Germany showed that in spring of 2020
compared to spring of 2019, there was a temporary decrease in specialist utilization, but
not in GP utilization among people with diabetes [44], whereas in the overall population,
utilization was temporarily decreased in both specialist and GP utilization [18]. This was
discussed as possibly being related to adaptions in the health care services by telephone
consultations, which were also captured by the study question on GP utilization, for people
with regularly required care of their GP [44].
4.2. Treatment Occasions
With regard to the relevant treatment occasions assessed in December 2020, the present
study revealed that the most required health care services were check-up visits at the GP,
specialist or dentist, which were also most frequently reported not to be available. This is
in line with previous reports highlighting that especially regular screening visits for cancer
and preventive medical check-ups were impacted by the lockdown in Germany [9,10].
This has also been reported in other countries like the UK, Australia and Taiwan [11–13].
Further research will determine whether postponed check-up and screening visits will
have a substantial impact on long term health outcomes like delayed diagnosis as reported
in several countries [28,45,46] or poorer health outcomes for already diagnosed chronic
diseases [47]. Scheduled hospital admissions or surgeries were less frequently required by
participants; however, more than one out of ten planned appointments were not available.
This is in line with an analysis of claims data on the hospital admissions during the COVID-
19 pandemic in Germany [21]. While during the first lockdown in March and April 2020, a
strong decrease up to one third of admissions compared to the same time period in 2019
has been observed, in November and December 2020, the decrease in utilization was less
severe, ranging from 17 to 20%.
However, not only scheduled check-up visits or hospital admissions, but also urgent
treatments were required and, according to the participants, not always available. An
extensive analysis from the UK showed that primary care contacts for almost all acute
physical and mental health conditions were significantly reduced during the lockdown in
March 2020 [17]. The most profound impact was observed for consultations for mental
health conditions. The present study also revealed an impact of the lockdown on the
access to psychotherapy treatments, for which the proportion of individuals reporting
non-availability of appointments was higher (16.5%) than for other surveyed treatment
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occasions (between 6.3% and 11.5%). As in Germany already prior to the pandemic, waiting
times for psychotherapy were higher compared to other specialties [48], the direct effect of
the lockdown on the availability of psychotherapy appointments cannot be differentiated.
However, the lockdown not only challenged the continuation of care of patients with
previously diagnosed psychiatric conditions, but also increased the need for consultation for
mental health complaints as a consequence of the lockdown and the COVID-19 pandemic
itself [49]. Several systematic reviews report that among others, the frequency of symptoms
of anxiety, depression, insomnia and psychological distress have significantly increased in
the general population during the COVID-19 pandemic [50–52]. In Germany, the impact
of the pandemic on mental health is less clear. An early analysis of the German National
Cohort showed an increase in depressive symptoms, especially in young people [53], which,
however, was not seen in the GEDA study [18]. To date, no clear evidence for an increase
in self-harming and suicidal behaviour has been observed [54]. In the early stage of the
pandemic, even a decrease in suicide rates was reported; however, this was followed by
an increase later in the pandemic. Therefore, the access to health care for prevention and
treatment of mental health problems should be one priority, and continuous research on
the topic is required [55,56].
4.3. Utilization and Satisfaction Regarding Telemedcine during the COVID-19 Pandemic
Telemedicine offers a broad range of opportunities to face the challenge in delivery of
care during the COVID-19 pandemic and can especially facilitate the interaction between
physicians and patients [32,57]. On the one hand, telemedicine enables contactless con-
sultation with patients having respiratory symptoms and reduces the risk for health care
professionals. On the other hand, telemedicine serves to reduce the risk of acquiring an
infection for appointments not related to COVID, especially for vulnerable groups such as
the chronically ill [58]. Additionally, in Germany, utilization of video consultation rose sig-
nificantly [10]. While in 2019, according to claims data from 70 million persons covered by
statutory health insurance only 200 video consultations per month were provided, in 2020,
more than 200,000 video consultations were documented. For psychotherapy treatments, a
survey from three European countries including Germany also showed an increase in the
utilization of video and telephone consultations [59]. In the present study, we analysed the
use of these telemedical consultation possibilities also stratified by personal characteristics
and further asked for the satisfaction with this alternative contact option. Our results
confirm that people with a required access to health care services reported a relatively
high utilization of telephone or video consultations, especially if perceived access was
limited. Only 7.5% of participants were not satisfied with these consultations. During the
COVID-19 pandemic, telemedicine was useful in many different medical disciplines and
both patients and healthcare providers reported high satisfaction [60].
However, our data also shows that access to telemedicine was not equally distributed.
Men stated to use both telephone and video consultations more often than women, and
participants with a higher educational background and of younger age reported to use
video consultations instead of physical visits more often than the other respective partic-
ipant subgroups. The latter findings are in line with a systematic review on the access
to telemedicine, which identified suitable technical equipment and familiarity with the
software systems as major facilitators of the telemedicine [61]. Telemedicine, however,
can only complement doctor visits in primary care, especially if examination, imaging
or lab tests are necessary either for the assessment of acute symptoms and screening or
long-term care. Yet, the increasing access to non-physical contacts via telephone and video
during the pandemic could push digitalization in the health service sector [32]. Video
consultation might become an integral part of doctor-patient communication in the future
and ensure the quality of care, especially in areas with less developed care structures;
however, equal access independent of age and educational status and high quality of care
must be guaranteed.
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4.4. Strength and Limitations
The COSMO study provides timely data on the perception, attitudes, knowledge
and behaviour of the general population in Germany during the COVID-19 pandemic.
The study is designed as a representative sample of the population aged 18 to 74 years.
However, a selection bias due to the relatively low response (<20%) [62] and the online
mode of the study cannot be excluded and might influence the generalizability of the study
results for the adult German population. Due to stratification the sample size in certain
strata was below a recommended threshold needed for reliable estimation of confidence
intervals [63]. Instead of implementing methods for calculating confidence intervals
for rare events [63] or sum up groups for higher statistically robustness, we preferred
being cautious with our interpretations. That is, that we used significantly in a statistical
meaning only for comparisons of strata with more than 30 persons. With regard to the
online sampling, persons reached might be more inclined to the utilization of telemedicine
services. Additionally, the elderly population is not included in the study; however, these
participants might be especially vulnerable in their need of access to health care and are
less likely to use telemedical services. Furthermore, similar to other population-based
surveys, multimorbid or institutionalized persons are hard to reach and therefore likely to
be underrepresented in the study.
5. Conclusions
The results of the COSMO study indicate that for the majority of the German popu-
lation aged 18–74 years medical appointments were available throughout the COVID-19
pandemic. However, perceived availability was reduced during lockdown periods and cor-
responded to the extent of the restrictions. Although, most persons with chronic conditions
have not reported limited access to health care, further analyses are required to assess the
impact of the lockdown for specific disease groups. Especially, the reduced availability and
utilization of preventive medical check-up visits, screenings and psychotherapy treatments
could have an effect on long term health outcomes such as the early diagnosis of cancer
and the quality of care of people with chronic diseases. The increased use of telemedicine
can complement the in-person visits and the COVID-19 pandemic could accelerate its
implementation, which should focus on equal access to telemedical offers regardless of age
or education.
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